AzTrials
AzTrials

Healthy Older AdultsNCT07039708

A Computer-based Memory Strategy Training Program for Older Adults

A study testing E-MinD Life Semantic and Cognitive stimulation in people with Healthy Older Adults and Memory Complaints, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

A computer-based cognitive rehabilitation program based on daily tasks utilising the semantic or perceptual encoding strategies called Enhancing Memory in Daily Life (E-MinD Life) has been developed for Chinese people. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
What is being tested?
E-MinD Life Semantic and Cognitive stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteHong Kong
Study dates
10 Feb 2025to Dec 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Group 1: healthy older adults aged 65 years or above Group 2: older adults aged 65 years or above with memory complaints Group 3: older adults aged 65 or above with mild cognitive impairment

Who cannot join

  • have depression and other clinical conditions that may affect their cognition.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The Hong Kong Polytechnic University

    Hong Kong, Hong Kong

Other trials in Hong Kong

About this study

Official title: A Computer-based Memory Strategy Training Program to Promote Everyday Performance in Healthy Older Adults, Older Adults With Memory Complaints, Mild Cognitive Impairment and Mild Dementia

A computer-based cognitive rehabilitation program based on daily tasks utilising the semantic or perceptual encoding strategies called Enhancing Memory in Daily Life (E-MinD Life) has been developed for Chinese people. The aim of the E-MinD Life is to delay functional deterioration associated with possible cognitive changes in healthy older adults, older adults with memory complaints, mild cognitive impairment (MCI) and mild dementia. This project will pilot-test the E-MinD Life in Chinese healthy older adults, older adults with memory complaints, MCI and mild dementia.

Read the detailed description

The objectives of the study are to investigate the feasibility and pilot-test the benefits of the computer-based E-MinD Life (Semantic) or (Perceptual) program to promote everyday performance in healthy older adults, older adults with memory complaints, mild cognitive impairment (MCI) and mild dementia in Hong Kong using a randomised control trial.

Three groups of participants will be recruited: (1) 15 healthy older adults, (2) 15 older adults aged over 65 years with memory complaints, or older adults aged over 65 years, meeting the diagnostic criteria for MCI with a Clinical Dementia Rating score of 0 or having mild dementia with a Clinical Dementia Rating score of 1. All participants will have no depression and other clinical conditions that may affect their cognition. Their scores on the Montreal Cognitive Assessment will be recorded. Their carers or family members are invited to participate.

Being tested
E-MinD Life Semantic, Cognitive stimulation
Keywords
computer-based, memory training, activities of daily living, older adults, feasibility
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • E-MinD Life SemanticBehavioural

    The E-MinD Life programme is designed to teach semantic or perceptual memory strategies. The memory strategies are applied to 12 common daily activities required for community living, e.g. meal preparation, laundry activities, and built into the E-MinD Life programme on a computer-based platform. The intervention runs over 9 weeks with one 45-minute individual face-to-face or online healthcare-professional-led session and two 30-minute, family-assisted home sessions per week. During the home sessions, participants will complete the same activities as those learnt during the healthcare-professional-led sessions. Family members or carers will be invited to join the healthcare-professional-led sessions as observers and support the participants in the home sessions if needed.

  • Cognitive stimulationBehavioural

    Participants will receive stimulation for visual attention and memory through online cognitive activities. The intervention will adopt a similar structure as the E-MinD Life group, with one 45-minute individual face-to-face or online healthcare-professional-led session and two 30-minute, family-assisted home sessions per week for 9 weeks.

Study groups in NCT07039708
Study groupRoleWhat they receive
E-MinD LifeExperimentalParticipants receive the E-MinD Life (Semantic or Perceptual) programme.
Receives: Behavioral: E-MinD Life Semantic
Cognitive stimulationActive comparatorParticipants will receive cognitive stimulation.
Receives: Behavioral: Cognitive stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accceptability

    Acceptability is measured using a structured questionnaire divided into five sections: (1) the therapist-led group sessions, (2) the self-administered individual sessions, and (3) the computer program interface and iPad usability, (4) the overall program design and structure and (5) overall satisfaction. Participants are invited to give quantitative ratings on four dimensions under each section: (a) perceived effectiveness (e.g., whether the program improved cognitive strategy use), (b) relevance (e.g., how applicable the activities were to daily life), (c) convenience (e.g., ease) and (d) clarity. Responses are collected using a 4-point Likert scale, ranging from 1 "Completely disagree" to 4 "Completely agree," with higher scores indicating greater acceptability.

    Measured: End of the intervention at 9 weeks

Secondary outcomes (6)
  1. Feasibility by measuring the attendance rate

    Feasibility by measuring the intervention attendance rate

    Measured: Through the intervention for 9 weeks, attendance at each session

  2. Consortium to Establish a Registry for Alzheimer's Disease - Neuropsychological Assessment Battery (CERAD-NAB)

    The CERAD-NAB provides a profile on cognitive function by assessing cognitive deficits and was validated in a Chinese version. This study will use all subtests, including Verbal Fluency (J1), Boston's Naming (J2), Mini-Mental State Examination (MMSE, J3), Word List Memory (J4), Constructional Praxis (J5), Word List Recall (J6), Word List Recognition (J7) and Recall of Constructional Praxis (J8). The total score ranges from 0 -115 with a higher score indicating better performance.

    Measured: From enrollment to the end of intervention at 9 weeks

  3. Digit Span Test

    The Digit Span Test consists of Digit Span Forward (DSF) and Digit Span Backward (DSB), measures immediate verbal recall, attentional capacity and working memory. The score is the number of digits in the longest successfully recalled sequence. A higher score indicates a better performance.

    Measured: From enrollment to the end of intervention at 9 weeks

  4. Lawton Instrumental Activities of Daily Living Scale

    The self-reported Lawton Instrumental Activities of Daily Living Scale-Chinese version (IADLS) assesses one's ability to independently perform eight domains of instrumental daily activities such as meal preparation, laundry work, and shopping. The scale consists of nine items, each rated on a 3-point or 4-point scale, with a total score ranging from 0 to 18 or higher. A higher score indicates a better performance

    Measured: From enrollment to the end of intervention at 9 weeks

  5. Disability Assessment for Dementia (DAD)

    The Chinese version of the Disability Assessment for Dementia (DAD) is a survey, completed by a proxy/carer, that evaluates the level of independence in daily activities for a person who has dementia or cognitive impairment. The DAD is scored based on a "yes/no" system, where "yes" indicates the person performed the activity without help, and "no" indicates they did not. The number of "yes" responses is totalled, and then converted to a percentage score out of 100. Higher percentage scores indicate better functional ability.

    Measured: From enrollment to the end of intervention at 9 weeks

  6. EuroQoL- 5 Dimensions - 5 Levels Hong Kong version (EQ-5D-5L_HK)

    The EQ-5D-5L HK measures health-related quality of life in five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, using five rating levels (33). The 5-level health status is converted to a utility value, ranging from 0 (death) to 1 (full health). The EQ-5D-5L HK includes a Visual Analogue Scale where respondents rate their overall health on a scale of 0 to 100.

    Measured: From enrollment to the end of intervention at 9 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2025
  2. Study start10 Feb 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Why it stopped: Because of the funding issue and the time limitation, the project has recruited healthy older adults. In the future, the project will resume to recruit older adults with memory complaints and mild cognitive impairments.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07039708
Sponsor's protocol ID
HongKongPU_E-MinD Life
Status last verified
Sep 2026
First submitted
18 Jun 2025
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The project is applying for external funding. The IPD will not be shared at this stage.

Questions about this trial

What is this clinical trial studying?

A study testing E-MinD Life Semantic and Cognitive stimulation in people with Healthy Older Adults and Memory Complaints, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accceptability (time frame: End of the intervention at 9 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in